Body mass index and body fat distribution and new-onset atrial fibrillation: Substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
07 2019
Historique:
received: 08 11 2018
revised: 06 02 2019
accepted: 06 03 2019
pubmed: 14 5 2019
medline: 25 2 2020
entrez: 14 5 2019
Statut: ppublish

Résumé

Obesity is a recognized risk factor for new-onset atrial fibrillation (AF). The association between body fat distribution, which is measured by body mass index (BMI) and waist-hip ratio (WHR), its changes, and new-onset AF is conflicting. Participants of the European Prospective Investigation into Cancer and Nutrition in Norfolk cohort study were included, with exclusion criteria of prevalent AF, rheumatic heart disease, and cancer. AF was confirmed by the International Classification of Diseases-10 hospital discharge code I48. Adjusted sex-specific Cox proportional hazards models were used to quantify the AF risk per 1 standard deviation increase and for quintiles of adiposity indices. A total of 10,885 men and 12,857 women were followed up for a median of 19 years, yielding 451,098 person-years. New-onset AF was diagnosed in 1408 (12.9%) men and 1102 (8.6%) women. Multivariable analyses showed that BMI predicted new-onset AF in all, while WHR predicted only in men. New-onset AF risk gradually increased across the range of adiposity indices: for men in the highest BMI quintile, HR: 1.59 (CI 1.32-1.91, p for trend<0.001), whereas for women in the highest BMI quintile, HR: 1.52 (CI 1.23-1.88, p for trend<0.001). Further, for men in the highest WHR quintile, HR: 1.31 (CI 1.09-1.57, p for trend: 0.01), whereas for women in the highest WHR quintile, HR: 1.12 (CI 0.90-1.41, p for trend: 0.17). The change in BMI and WHR was similar in participants with or without new-onset AF. An increased body mass, as measured by BMI, is associated with an increased risk of developing new-onset AF. More abdominal fat distribution, as measured by WHR, is associated with an increased risk of developing new-onset AF in men but not in women.

Sections du résumé

BACKGROUND AND AIM
Obesity is a recognized risk factor for new-onset atrial fibrillation (AF). The association between body fat distribution, which is measured by body mass index (BMI) and waist-hip ratio (WHR), its changes, and new-onset AF is conflicting.
METHODS AND RESULTS
Participants of the European Prospective Investigation into Cancer and Nutrition in Norfolk cohort study were included, with exclusion criteria of prevalent AF, rheumatic heart disease, and cancer. AF was confirmed by the International Classification of Diseases-10 hospital discharge code I48. Adjusted sex-specific Cox proportional hazards models were used to quantify the AF risk per 1 standard deviation increase and for quintiles of adiposity indices. A total of 10,885 men and 12,857 women were followed up for a median of 19 years, yielding 451,098 person-years. New-onset AF was diagnosed in 1408 (12.9%) men and 1102 (8.6%) women. Multivariable analyses showed that BMI predicted new-onset AF in all, while WHR predicted only in men. New-onset AF risk gradually increased across the range of adiposity indices: for men in the highest BMI quintile, HR: 1.59 (CI 1.32-1.91, p for trend<0.001), whereas for women in the highest BMI quintile, HR: 1.52 (CI 1.23-1.88, p for trend<0.001). Further, for men in the highest WHR quintile, HR: 1.31 (CI 1.09-1.57, p for trend: 0.01), whereas for women in the highest WHR quintile, HR: 1.12 (CI 0.90-1.41, p for trend: 0.17). The change in BMI and WHR was similar in participants with or without new-onset AF.
CONCLUSIONS
An increased body mass, as measured by BMI, is associated with an increased risk of developing new-onset AF. More abdominal fat distribution, as measured by WHR, is associated with an increased risk of developing new-onset AF in men but not in women.

Identifiants

pubmed: 31079869
pii: S0939-4753(19)30089-4
doi: 10.1016/j.numecd.2019.03.005
pmc: PMC7340538
mid: EMS86620
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

692-700

Subventions

Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Références

Br J Cancer. 1999 Jul;80 Suppl 1:95-103
pubmed: 10466767
J Am Coll Cardiol. 2012 Aug 28;60(9):851-60
pubmed: 22726633
J Am Coll Cardiol. 2014 Dec 2;64(21):2222-31
pubmed: 25456757
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38
pubmed: 24222017
Eur J Prev Cardiol. 2015 Jul;22(7):932-9
pubmed: 25059930
J Am Coll Cardiol. 2015 Sep 1;66(9):985-96
pubmed: 26113406
J Am Coll Cardiol. 2010 May 25;55(21):2319-27
pubmed: 20488302
Obesity (Silver Spring). 2014 Jun;22(6):1546-52
pubmed: 24436019
Am J Med. 2005 May;118(5):489-95
pubmed: 15866251
Circulation. 2007 Dec 18;116(25):2933-43
pubmed: 18071080
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):62-73
pubmed: 19808395
Arch Intern Med. 2006 Nov 27;166(21):2322-8
pubmed: 17130384
J Am Coll Cardiol. 2017 May 23;69(20):2488-2497
pubmed: 28521886
Am Heart J. 2008 Feb;155(2):310-5
pubmed: 18215602
J Am Coll Cardiol. 2015 May 26;65(20):2159-69
pubmed: 25792361
JAMA. 2004 Nov 24;292(20):2471-7
pubmed: 15562125
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
J Am Coll Cardiol. 2015 Jul 7;66(1):1-11
pubmed: 26139051
Circ Arrhythm Electrophysiol. 2016 Dec;9(12):
pubmed: 27923804
Heart Rhythm. 2013 Jan;10(1):90-100
pubmed: 23063864
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
JAMA. 2013 Nov 20;310(19):2050-60
pubmed: 24240932
Transl Res. 2014 Oct;164(4):323-35
pubmed: 24880146

Auteurs

J Neefs (J)

Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, the Netherlands.

S M Boekholdt (SM)

Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, the Netherlands.

K-T Khaw (KT)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

R Luben (R)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

R Pfister (R)

Department III of Internal Medicine, Heart Centre of the University of Cologne, Germany.

N J Wareham (NJ)

MRC Epidemiology Unit, Cambridge, United Kingdom.

E R Meulendijks (ER)

Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, the Netherlands.

P Sanders (P)

Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.

J R de Groot (JR)

Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: j.r.degroot@amc.uva.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH